AstraZeneca, Amgen partner with FDA to test real-time AI trial monitoring
Go back to AstraZeneca, Amgen partner with FDA to test real-time AI trial monitoring| Amgen Inc (NASDAQ: AMGN) | Delayed: 377.35 -5.12 (1.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $382.47 | 52 Week High | $176.85 | |||
| Open | $386.14 | 52 Week Low | $133.64 | |||
| Day High | $386.99 | P/E | 56.83 | |||
| Day Low | $377.22 | EPS | $6.64 | |||
| Volume | 2,291,464 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 2,228,429 | |||||
